OOIR: Observatory of International Research

Papers

(The median citation count of Clinical Microbiology Reviews is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
2025 Acknowledgment of CMR Reviewers	261
Extracutaneous sporotrichosis	237
Vaccines and monoclonal antibodies to prevent healthcare-associated bacterial infections	188
Wild-type distributions of minimum inhibitory concentrations and epidemiological cut-off values—laboratory and clinical utility	187
Integrating whole-genome sequencing into antimicrobial resistance surveillance: methodologies, challenges, and perspectives	147
Erratum for Nyaruaba et al., “Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks”	142
Antibiotic tolerance among clinical isolates: mechanisms, detection, prevalence, and significance	130
The long reach of influenza and other respiratory viruses: from acute epithelial injury to post-viral lung disease	129
The sex hormone-gut microbiome axis: mechanistic drivers of sex-disparate bacterial infection outcomes and precision clinical interventions	120
Progression of antibiotic resistance in Neisseria meningitidis	113
Viral infections and pathogenesis of glaucoma: a comprehensive review	113
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	104
Emerging hybrid shigatoxigenic and enteropathogenic Escherichia coli serotype O80:H2 in humans and calves	101
Mechanisms of microbial colonization in biofilm-associated infections of hemodialysis catheters and advances in surface modification technologies	94
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities	93
A review of post-exposure strategies for high-consequence viral pathogens in the laboratory	89
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus	89
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options	89
Decontamination approaches and strategies for the prevention of sink drain-related healthcare-associated infections	87
Canonical fact versus hypothesis testing to decipher transmission of non-tuberculous and tuberculous mycobacteria: a comparative review	80
Review of BCG immunotherapy for bladder cancer	79
Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics	79
Non- faecium non- faecalis enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance	77
Neisseria gonorrhoeae vaccines: a contemporary overview	75
Clonorchiasis and opisthorchiasis: epidemiology, transmission, clinical features, morbidity, diagnosis, treatment, and control	74

Congenital Syphilis: a Review of Global Epidemiology	71
Drug-resistant Acinetobacter baumannii : mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen	67
Extrapolation and comparison of West Nile virus- and Usutu virus-associated neurological diseases in humans: linking pathology to clinical symptoms	66
Erratum for Cho et al., “Recent advances in therapeutic probiotics: insights from human trials”	64
An unintended consequence: a review of iatrogenic central nervous system mold infections and outbreaks	62
BCG therapy in bladder cancer and its tumor microenvironment interactions	61
Bacterial and fungal infections in persons who inject drugs	60
Serratia species as paratransgenic vehicles: potential applications in vector-borne disease control	58
Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungi	56
The ecological dynamics of skin microbiota in skin health and diseases	55
Implementation of pathogen genomics in clinical microbiology laboratories	53
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease	53
Diagnosis, Management, and Future Control of Cholera	49
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	46
Rapid and accurate testing for urinary tract infection: new clothes for the emperor	45
Plasmids in Neisseria gonorrhoeae : drivers of DoxyPEP failure and an emerging threat for current therapy	45
Convalescent plasma for COVID-19: planning for the next pandemic using the worldwide experience	42
The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections	42
Harnessing the host response for precision infectious disease diagnosis	41
Lyme borreliosis in Brazil: a critical review on the Baggio–Yoshinari syndrome (Brazilian Lyme-like disease)	40
Mechanistic insights into the pathogenesis and therapeutic recalcitrance of Staphylococcus aureus osteomyelitis	40
Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome	40
Agnostic Sequencing for Detection of Viral Pathogens	39
Artemisinin-resistant malaria	39
Editorial Board	36
From antibiotic to peptide siderophore conjugates as modular strategies against multidrug-resistant bacteria	35
The challenges of difficult-to-treat Acinetobacter infections	33
COVID-19 therapeutics	33
Pneumocystis jirovecii pneumonia in people living with HIV: a review	31
IgY passive immunotherapy for pandemic preparedness: a One Health platform approach against pathogen X	31
Floods and infectious diseases: public health lessons from the 2024 southern Brazil disaster	31
Pathogenesis of viral infections during pregnancy	30
The oral penems and carbapenems	28
An update on Clostridioides difficile population structure and genomics	28
Editorial Board	27
An updated list of eumycetoma causative agents and their differences in grain formation and treatment response	27
Challenges for global antibiotic regimen planning and establishing antimicrobial resistance targets: implications for the WHO Essential Medicines List and AWaRe antibiotic book dosing	27
Osteoarticular Mycoses	24
Erratum for Gopalaswamy and Subbian, “The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tub	24
Invasive fusariosis	23
Updated Review onNocardiaSpecies: 2006–2021	23
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease	23
Human toxocariasis	23
Coenzyme A metabolism in fungi: a new frontier in antifungal therapy	22
From surveillance to stewardship: addressing antimicrobial resistance in Central Asia’s healthcare	22
Schistosomiasis: cercarial finding and recognizing of human hosts as a prerequisite of invasion	22
Clinical Microbiology Reviews : a 21st century vision	22
Narrative review on bacteria-derived metabolites in the pathogenesis of ulcerative colitis	21
Environmental and physiological factors influencing the survival of resistant Salmonella under infection-related gut conditions	21
Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective	21

Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management	21
Skin microbiota in atopic dermatitis: victim or executioner?	21
The endothelium at the interface between tissues and Staphylococcus aureus in the bloodstream	20
Host Immunity and Immunization Strategies for Clostridioides difficile Infection	20
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities	20
Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice	19
Infection prevention and control in low- and middle-income countries: policy, practice, and implementation challenges in sub-Saharan Africa	19
Surveillance and prevention of infection in clinical xenotransplantation	18
Current perspectives in the epidemiology and control of lymphatic filariasis	18
The American Society for Microbiology’s evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests: a systematic review and meta-analysis	17
A call for the United States to continue investing in science	17
Masks and respirators for prevention of respiratory infections: a state of the science review	17
Advancements and challenges in antifungal therapeutic development	17
Streptococcus pneumoniae β-lactam resistance: epidemiological trends, molecular drivers, and innovative control strategies in the post-pandemic era	16
Correction for Moreland et al., “Rapid and accurate testing for urinary tract infection: new clothes for the emperor”	15
Human Listeriosis	15
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections	15
2023 Acknowledgment of CMR Reviewers	14
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells	14
Neurological complications caused by SARS-CoV-2	14
A narrative review of coagulase-negative staphylococci in diabetic foot infections	13
Global emergence and rapid spread of Candidozyma auris (syn. Candida auris ): epidemiology, biology, and a	13
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies	13
Optimized use and performance of culture for periprosthetic joint infection diagnosis: a comprehensive literature review	12
Fastidious or rarely isolated gram-negative rods with a particular focus on Kingella kingae	12